Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
M&A
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(349)
1 / 18
Psych R&D
Rebuilding the Psychiatric Drug Discovery Pipeline
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-14
May 13, 2026
M&A
ROIS CDMO Closes on the Acquisition of US Injectable Manufacturing Facility
ROIS
PR-04-26-01
Apr 1, 2026
M&A
Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, Maryland
Samsung Biologics
PR-03-26-02
Mar 31, 2026
Biotech Funding
Selective Capital, Stronger Science: The Emerging Biotech Funding Model
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-04
Jan 6, 2026
M&A
How are capital constraints impacting M&A and strategic partnerships in the CDMO and pharma sectors?
Pharma's Almanac
PAO-01-26-RT-02
Jan 5, 2026
M&A
Fewer, Bigger, Smarter: How Pharma M&A Evolved in 2025 — and What Comes Next
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-07
Dec 17, 2025
M&A
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland
Microsize
PR-11-25-NI-10
Nov 24, 2025
Pharma Packaging
Ampersand Capital Partners Invests in CurTec, a Global Leader in Pharma & Specialty Chemicals Bulk Packaging
Ampersand Capital Partners
PR-07-25-NI-1
Jul 21, 2025
CDMO Acquisition
TCP Analytical, Backed by Riverarch, Audax, Hillman, Lacy Diversified, and PPM America, Acquires Alconox, LLC
Alconox Inc.
PR-07-03-NI-13
Jul 3, 2025
Acquisition
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services
PR-04-25-NI-05
Apr 24, 2025
Acquirement
Lilly to Acquire Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program
Eli Lilly and Company
PR-01-25-NI-14
Jan 14, 2025
Axonics
Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific
PR-11-24-NI-105
Nov 15, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
Recipharm Advanced Bio
PAO-10-24-CL-13
Oct 25, 2024
Financing
Why Life Science Companies Surged amid a Global M&A Downturn
Amanda Wang
That's Nice LLC
PAO-10-24-CL-11
Oct 15, 2024
M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01
Sep 4, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01
Jul 2, 2024
Vantage Nutrition LLC Acquires ComboCap Inc
Vantage Solutions
PR-M03-23-07
Mar 27, 2023
M&A
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
Pluristyx
PR-M10-22-04
Oct 6, 2022
Integration
Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse
Actylis
PR-M09-22-06-262
Sep 26, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
Sep 7, 2022
1 / 18